Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01137825 · ClinicalTrials.gov registry record
Registry of Older Patients With Cancer
A clinical trial of Lymphoma and Leukemia, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Recruiting
- Registry status
- 3,000
- Enrollment target
- 7
- Study locations
NCT01137825: Recruiting study of Lymphoma and Leukemia, sponsored by UNC Lineberger Comprehensive Cancer Center.
NCT01137825 is a study of Lymphoma and Leukemia that is actively recruiting participants, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 3,000 participants, above the 474-participant average among 299 other Lymphoma trials with a reported enrollment target (533% higher). The trial reports 7 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01137825, a study of Lymphoma and Leukemia, is actively recruiting participants, sponsored by UNC Lineberger Comprehensive Cancer Center.
- RECRUITING
- Registry status
- 3,000 participants
- Enrollment target
- 7
- Study locations
Study Summary
RATIONALE: Gathering information about older patients with cancer may help the study of cancer in the future. PURPOSE: This research study is gathering information from older patients with cancer into a registry.
Conditions Studied
Study Locations (7)
North Carolina
- Seby B. Jones Cancer Center - Boone
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill - Chapel Hill
- East Carolina University - Greenville
- Pardee Cancer Center - Hendersonville
- Carteret Health Care Cancer Center - Morehead City
- Carolina East Radiology - New Bern
- Rex Healthcare - Raleigh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2009-09 |
| Est. Completion | 2030-12 |
What NCT01137825 shows while recruiting
NCT01137825 is an observational study that tracks outcomes without assigning an intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus, above the 474-participant average among 299 other Lymphoma trials with a reported enrollment target (533% higher).
The record links to 9 conditions, with Lymphoma appearing as the primary indexed condition, and to 0 interventions.
NCT01137825 lists 7 locations in 1 state (North Carolina).
Frequently Asked Questions
What is clinical trial NCT01137825 about?
NCT01137825 is a clinical study titled "Registry of Older Patients With Cancer". RATIONALE: Gathering information about older patients with cancer may help the study of cancer in the future. PURPOSE: This research study is gathering information from older patients with cancer into a registry.
What is the current status of trial NCT01137825?
This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 2009-09. Estimated completion is 2030-12.
What conditions does trial NCT01137825 study?
This clinical trial studies the following conditions: Lymphoma, Leukemia, Myelodysplastic Syndromes, Unspecified Adult Solid Tumor, Protocol Specific, Multiple Myeloma and Plasma Cell Neoplasm.
Who is sponsoring clinical trial NCT01137825?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01137825 being conducted?
This trial has 7 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01137825's enrollment target sits among peer trials
3,000 3rd of 299 higher than 296 of 299 other Lymphoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lymphoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
RECRUITING · NA
-
Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
RECRUITING · Phase 2
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
RECRUITING · Early Phase 1
-
A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma
RECRUITING · Phase 1
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia